The Fas and Fas ligand pathways in liver allograft tolerance

Clinical and Experimental Immunology

Volumn 118, Issue 1, 1999, Pages 180-187

  Pan, T L ^a   Goto, Shigeru ^a   Lin, Y C ^a   Lord, R ^b   Chiang, K C ^a   Lai, C Y ^a   Chen, Y S ^a   Eng, H L ^a   Cheng, Y F ^a   Tatsuma, T ^c   Kitano, S ^c   Lin, C L ^a   Chen, C L ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Department of Surgery I ^*  (Japan)

Author keywords

Fas; Fas ligand; Liver transplantation; Rat; Tolerance

Indexed keywords

FAS LIGAND;

ALLOGRAFT; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; LIGAND BINDING; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD95; FAS LIGAND PROTEIN; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 0032867152     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01035.x     Document Type: Article

References (33)

1. 1 Calne RY, Sells RA, Rena JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223:472-6.
2. 2 Kamada N, Davies HFFS, Roser BJ. Reversal of transplantation immunity by liver grafting. Nature 1981; 292:840-2.
3. 3 Kamada N, Brons G, Davies HffS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980; 29:429-31.
4. 4 Kamada N, Kobayashi E, Goto S. Liver transplantation in the rat. In: Green MK, Mandel TE, eds. Experimental transplantation models in small animals. Chur, Switzerland: Harwood Academic Publishers, 1995:341-52.
5. 5 Kamada N, Shinomiya T. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology 1985; 55:85-86.
6. 6 Yoshimura S, Goto S, Kamada N. Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity. Clin Exp Immunol 1991; 85:121-7.
7. 7 Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in induction self tolerance. Science 1990; 248:1343-5.
8. 8 Starzl TE, Demetris AJ, Murase N et al. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339:1579.
9. 9 Sun J, McCaughan GW, Gallagher ND et al. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995; 60:233-6.
10. 10 Chiba S, Goto S, Shimizu Y et al. The characterisation of reconstituted passenger leukocytes on the induction of tolerance in rat liver transplantation. Transpl Int 1997; 10:350-6.
11. 11 Sumimoto R, Kamada N. Evidence that soluble class I antigen in donor serum induces the suppression of heart allograft rejection in rats. Immunol Letters 1990; 26:81-84.
12. 12 Goto S, Kamada N, Lord R, Kobayashi E, Enosawa S, Kim Y. Induction of natural chimerism after retransplantation of the liver in rats. Transplantation 1994; 58:1230-5.
13. 13 Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 1990; 26:81-86.
14. 14 Nicholas C, Mehal WZ. Strange brew - T cells in the liver. Immunol Today 1996; 17:522-5.
15. 15 Crispe N, Flavell R, Leeker M et al. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994; 1:741-9.
16. 16 Bellgrau D, Gold D, Selawry H et al. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-2.
17. 17 Yamagami S, Kawashima H, Tsuru T et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997; 64:1107-11.
18. 18 Wang JD, Nonomura N, Ichimaru N et al. Expression of Fas and Fas ligand in renal grafts with acute and chronic rejection in the rat model. Int J Cytokine Res 1997; 17:369-73.
19. 19 Nagata S, Colstein P. The Fas death factor. Science 1995; 267:1447-56.
20. 20 Nagata S. Fas ligand and immune evasion. Nature Med 1996; 2:1306.
21. 21 Xerri L, Devilard E, Hassoun J et al. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. J Clin Palhol: Mol Pathol 1997; 50:87-91.
22. 22 Strand S, Hofmann WJ, Hug H et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumour cells - a mechanism of immune evasion? Nature Med 1996; 2:1361.
23. 23 Nagata S. Apoptosis by death factor. Cell 1997; 88:355-65.
24. 24 Li XK, Kita Y, Tamura A et al. Activation of Fas and Perforin pathways in rat liver allograft rejection. Transplant Proc 1998; 30:19-21.
25. 25 Allison J, Georgiou HM, Strasser A et al. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infilration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 1997; 94:3943-7.
26. 26 Kang SM, Schneider DB, Lin Z et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med 1997; 3:738-43.
27. 27 Tanaka M, Itai T, Adachi M et al. Downregulation of Fas ligand by shedding. Nature Med 1998; 4:31-36.
28. 28 Strasser A, Oconnor L. Fas ligand - caught between Scylla and Charybdis. Nature Med 1998;4:21-22.
29. 29 Miwa K, Asano M, Horai R et al. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand. Nature Med 1998; 4:1287-92.
30. 30 Krams SM, Fox CK, Beatty PR et al. Human hepatocytes produce an isoform of Fas that inhibits apoptosis. Transplantation 1998; 65:713-21.
31. 31 Jodo S, Kobayashi S, Nakajima Y et al. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma. Clin Exp Immunol 1998; 112:166-71.
32. 32 Strand S, Hofmann WT, Grambiher A et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nature Med 1998; 4:588-93.
33. 33 Adachi M, Suematsu S, Kondo T et al. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet 1995; 11:294-9.